Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches.

Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches.

Item
http://www.wikidata.org/entity/Q36561847
Targeting xenobiotic receptors PXR and CAR in human diseasesPathway analysis for drug repositioning based on public database miningPharmacophore and 3D-QSAR characterization of 6-arylquinazolin-4-amines as Cdc2-like kinase 4 (Clk4) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) inhibitorsQuantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor.Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors.1001 Ways to run AutoDock Vina for virtual screeningGenome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cellsRegulation of gene expression by CAR: an update.Mechanisms of xenobiotic receptor activation: Direct vs. indirect.The regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors.Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes.Teriflunomide Is an Indirect Human Constitutive Androstane Receptor (CAR) Activator Interacting With Epidermal Growth Factor (EGF) Signaling
P2860

Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches.

Item
http://www.wikidata.org/entity/Q36561847
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Identification of novel activa ...... nal and biological approaches.
@ast
Identification of novel activa ...... nal and biological approaches.
@en
type
label
Identification of novel activa ...... nal and biological approaches.
@ast
Identification of novel activa ...... nal and biological approaches.
@en
prefLabel
Identification of novel activa ...... nal and biological approaches.
@ast
Identification of novel activa ...... nal and biological approaches.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Identification of novel activa ...... nal and biological approaches.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932